Annual EBITDA
-$42.37 M
+$14.34 M+25.28%
December 31, 2023
Summary
- As of March 4, 2025, PLSE annual EBITDA is -$42.37 million, with the most recent change of +$14.34 million (+25.28%) on December 31, 2023.
- During the last 3 years, PLSE annual EBITDA has risen by +$6.50 million (+13.31%).
- PLSE annual EBITDA is now -1029.49% below its all-time high of -$3.75 million, reached on December 31, 2015.
Performance
PLSE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.36 M
-$1.93 M-16.91%
September 30, 2024
Summary
- As of March 4, 2025, PLSE quarterly EBITDA is -$13.36 million, with the most recent change of -$1.93 million (-16.91%) on September 30, 2024.
- Over the past year, PLSE quarterly EBITDA has stayed the same.
- PLSE quarterly EBITDA is now -2256.44% below its all-time high of -$567.00 thousand, reached on March 31, 2015.
Performance
PLSE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$47.33 M
-$2.41 M-5.36%
September 30, 2024
Summary
- As of March 4, 2025, PLSE TTM EBITDA is -$47.33 million, with the most recent change of -$2.41 million (-5.36%) on September 30, 2024.
- Over the past year, PLSE TTM EBITDA has stayed the same.
- PLSE TTM EBITDA is now -8248.15% below its all-time high of -$567.00 thousand, reached on March 31, 2015.
Performance
PLSE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PLSE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.3% | 0.0% | 0.0% |
| 3 y3 years | +13.3% | 0.0% | 0.0% |
| 5 y5 years | -15.6% | 0.0% | 0.0% |
PLSE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.5% | -58.9% | +24.4% | -22.8% | +25.4% |
| 5 y | 5-year | at high | +31.5% | -58.9% | +26.8% | -22.8% | +25.4% |
| alltime | all time | -1029.5% | +31.5% | -2256.4% | +26.8% | -8248.1% | +25.4% |
Pulse Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.36 M(+16.9%) | -$47.33 M(+5.4%) |
| Jun 2024 | - | -$11.43 M(+10.8%) | -$44.93 M(+3.5%) |
| Mar 2024 | - | -$10.32 M(-15.6%) | -$43.42 M(+2.5%) |
| Dec 2023 | -$42.37 M(-25.3%) | -$12.23 M(+11.6%) | -$42.37 M(+9.9%) |
| Sep 2023 | - | -$10.95 M(+10.4%) | -$38.55 M(-14.9%) |
| Jun 2023 | - | -$9.93 M(+7.2%) | -$45.28 M(-7.6%) |
| Mar 2023 | - | -$9.26 M(+10.1%) | -$49.02 M(-13.6%) |
| Dec 2022 | -$56.70 M(-8.4%) | -$8.41 M(-52.5%) | -$56.70 M(-10.6%) |
| Sep 2022 | - | -$17.69 M(+29.5%) | -$63.41 M(+6.2%) |
| Jun 2022 | - | -$13.66 M(-19.4%) | -$59.71 M(-1.4%) |
| Mar 2022 | - | -$16.95 M(+12.1%) | -$60.57 M(-2.1%) |
| Dec 2021 | -$61.87 M(+26.6%) | -$15.11 M(+8.1%) | -$61.87 M(+2.7%) |
| Sep 2021 | - | -$13.99 M(-3.7%) | -$60.23 M(+2.3%) |
| Jun 2021 | - | -$14.52 M(-20.4%) | -$58.88 M(+6.2%) |
| Mar 2021 | - | -$18.25 M(+35.4%) | -$55.44 M(+13.4%) |
| Dec 2020 | -$48.87 M(+4.4%) | -$13.47 M(+6.5%) | -$48.87 M(-0.4%) |
| Sep 2020 | - | -$12.64 M(+14.1%) | -$49.06 M(+1.9%) |
| Jun 2020 | - | -$11.08 M(-5.2%) | -$48.13 M(-0.6%) |
| Mar 2020 | - | -$11.68 M(-14.5%) | -$48.39 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.79 M(+27.7%) | -$13.66 M(+16.7%) | -$46.79 M(+11.8%) |
| Sep 2019 | - | -$11.71 M(+3.2%) | -$41.86 M(+2.8%) |
| Jun 2019 | - | -$11.35 M(+12.5%) | -$40.70 M(+6.2%) |
| Mar 2019 | - | -$10.08 M(+15.6%) | -$38.33 M(+4.6%) |
| Dec 2018 | -$36.65 M(+47.7%) | -$8.72 M(-17.3%) | -$36.65 M(+0.5%) |
| Sep 2018 | - | -$10.55 M(+17.5%) | -$36.45 M(+10.1%) |
| Jun 2018 | - | -$8.98 M(+6.8%) | -$33.12 M(+9.8%) |
| Mar 2018 | - | -$8.40 M(-1.4%) | -$30.17 M(+21.6%) |
| Dec 2017 | -$24.81 M(+181.1%) | -$8.53 M(+18.2%) | -$24.81 M(+31.0%) |
| Sep 2017 | - | -$7.21 M(+19.6%) | -$18.94 M(+32.1%) |
| Jun 2017 | - | -$6.03 M(+97.9%) | -$14.34 M(+38.1%) |
| Mar 2017 | - | -$3.05 M(+14.9%) | -$10.38 M(+17.6%) |
| Dec 2016 | -$8.83 M(+135.3%) | -$2.65 M(+1.7%) | -$8.83 M(+17.3%) |
| Sep 2016 | - | -$2.61 M(+25.9%) | -$7.52 M(+26.0%) |
| Jun 2016 | - | -$2.07 M(+38.4%) | -$5.97 M(+27.6%) |
| Mar 2016 | - | -$1.50 M(+11.0%) | -$4.68 M(+24.8%) |
| Dec 2015 | -$3.75 M | -$1.35 M(+27.7%) | -$3.75 M(+56.1%) |
| Sep 2015 | - | -$1.06 M(+35.4%) | -$2.40 M(+78.4%) |
| Jun 2015 | - | -$780.00 K(+37.6%) | -$1.35 M(+137.6%) |
| Mar 2015 | - | -$567.00 K | -$567.00 K |
FAQ
- What is Pulse Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Pulse Biosciences?
- What is Pulse Biosciences annual EBITDA year-on-year change?
- What is Pulse Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pulse Biosciences?
- What is Pulse Biosciences quarterly EBITDA year-on-year change?
- What is Pulse Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Pulse Biosciences?
- What is Pulse Biosciences TTM EBITDA year-on-year change?
What is Pulse Biosciences annual EBITDA?
The current annual EBITDA of PLSE is -$42.37 M
What is the all time high annual EBITDA for Pulse Biosciences?
Pulse Biosciences all-time high annual EBITDA is -$3.75 M
What is Pulse Biosciences annual EBITDA year-on-year change?
Over the past year, PLSE annual EBITDA has changed by +$14.34 M (+25.28%)
What is Pulse Biosciences quarterly EBITDA?
The current quarterly EBITDA of PLSE is -$13.36 M
What is the all time high quarterly EBITDA for Pulse Biosciences?
Pulse Biosciences all-time high quarterly EBITDA is -$567.00 K
What is Pulse Biosciences quarterly EBITDA year-on-year change?
Over the past year, PLSE quarterly EBITDA has changed by $0.00 (0.00%)
What is Pulse Biosciences TTM EBITDA?
The current TTM EBITDA of PLSE is -$47.33 M
What is the all time high TTM EBITDA for Pulse Biosciences?
Pulse Biosciences all-time high TTM EBITDA is -$567.00 K
What is Pulse Biosciences TTM EBITDA year-on-year change?
Over the past year, PLSE TTM EBITDA has changed by $0.00 (0.00%)